Evaxion Biotech As Stock Alpha and Beta Analysis
| EVAX Stock | USD 1.57 0.04 2.48% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Evaxion Biotech AS. It also helps investors analyze the systematic and unsystematic risks associated with investing in Evaxion Biotech over a specified time horizon. Remember, high Evaxion Biotech's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Evaxion Biotech's market risk premium analysis include:
Beta 0.32 | Alpha (0.93) | Risk 5.72 | Sharpe Ratio (0.16) | Expected Return (0.93) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Evaxion |
Evaxion Biotech Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Evaxion Biotech market risk premium is the additional return an investor will receive from holding Evaxion Biotech long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Evaxion Biotech. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Evaxion Biotech's performance over market.| α | -0.93 | β | 0.32 |
Evaxion Biotech expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Evaxion Biotech's Buy-and-hold return. Our buy-and-hold chart shows how Evaxion Biotech performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Evaxion Biotech Market Price Analysis
Market price analysis indicators help investors to evaluate how Evaxion Biotech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Evaxion Biotech shares will generate the highest return on investment. By understating and applying Evaxion Biotech stock market price indicators, traders can identify Evaxion Biotech position entry and exit signals to maximize returns.
Evaxion Biotech Return and Market Media
The median price of Evaxion Biotech for the period between Sat, Aug 31, 2024 and Fri, Nov 29, 2024 is 2.76 with a coefficient of variation of 21.01. The daily time series for the period is distributed with a sample standard deviation of 0.56, arithmetic mean of 2.66, and mean deviation of 0.41. The Stock received a lot of media exposure during the period. Price Growth (%) |
| Timeline |
1 | Evaxion obtains pre-clinical Proof-of-Concept for mRNA Gonorrhea vaccine candidate EVX-B2 | 09/09/2024 |
2 | Evaxion reports convincing one-year data from phase 2 trial on AI-designed personalized cancer vaccine EVX-01 | 09/16/2024 |
3 | H.C. Wainwright keeps buy rating on Evaxion stock, cites promising AI-powered cancer vaccine - Investing.com | 09/20/2024 |
4 | Evaxion stock jumps on expanded vaccine development pact with MSD | 09/26/2024 |
5 | Recent clinical data confirms significantly improved predictive power of Evaxions AI-Immunology platform | 10/03/2024 |
6 | Strong validation of Evaxions AI-Immunology platform in multiple clinical trials | 10/09/2024 |
7 | Evaxion to announce business update and third quarter 2024 financial results on October 31 | 10/28/2024 |
8 | Evaxion announces business update and third quarter 2024 financial results | 10/31/2024 |
9 | ARMISTICE CAPITAL, LLC Acquires Shares in Evaxion Biotech AS - GuruFocus.com | 11/14/2024 |
10 | Evaxion Biotech stock hits 52-week low at 1.31 - Investing.com | 11/21/2024 |
About Evaxion Biotech Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Evaxion or other stocks. Alpha measures the amount that position in Evaxion Biotech AS has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2023 | 2024 (projected) | Graham Number | 17.75 | 33.51 | Receivables Turnover | 0.0611 | 0.0543 |
Evaxion Biotech Upcoming Company Events
As portrayed in its financial statements, the presentation of Evaxion Biotech's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Evaxion Biotech's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Evaxion Biotech's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Evaxion Biotech. Please utilize our Beneish M Score to check the likelihood of Evaxion Biotech's management manipulating its earnings.
| 25th of April 2024 Upcoming Quarterly Report | View | |
| 29th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 25th of April 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Evaxion Biotech
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Evaxion Stock Analysis
When running Evaxion Biotech's price analysis, check to measure Evaxion Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evaxion Biotech is operating at the current time. Most of Evaxion Biotech's value examination focuses on studying past and present price action to predict the probability of Evaxion Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evaxion Biotech's price. Additionally, you may evaluate how the addition of Evaxion Biotech to your portfolios can decrease your overall portfolio volatility.